| Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome–dependent processing of IL-1β BB Mishra, VAK Rathinam, GW Martens, AJ Martinot, H Kornfeld, ... Nature immunology 14 (1), 52-60, 2013 | 651 | 2013 |
| Mycobacterium tuberculosis protein ESAT‐6 is a potent activator of the NLRP3/ASC inflammasome BB Mishra, P Moura‐Alves, A Sonawane, N Hacohen, G Griffiths, LF Moita, ... Cellular microbiology 12 (8), 1046-1063, 2010 | 422 | 2010 |
| Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis BB Mishra, RR Lovewell, AJ Olive, G Zhang, W Wang, E Eugenin, ... Nature microbiology 2 (7), 1-11, 2017 | 284 | 2017 |
| Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages A Sonawane, JC Santos, BB Mishra, P Jena, C Progida, OE Sorensen, ... Cellular microbiology 13 (10), 1601-1617, 2011 | 200 | 2011 |
| The oxidative stress network of Mycobacterium tuberculosis reveals coordination between radical detoxification systems S Nambi, JE Long, BB Mishra, R Baker, KC Murphy, AJ Olive, HP Nguyen, ... Cell host & microbe 17 (6), 829-837, 2015 | 190 | 2015 |
| NF-κB activation controls phagolysosome fusion-mediated killing of mycobacteria by macrophages MG Gutierrez, BB Mishra, L Jordao, E Elliott, E Anes, G Griffiths The Journal of Immunology 181 (4), 2651-2663, 2008 | 148 | 2008 |
| Tuberculosis susceptibility and vaccine protection are independently controlled by host genotype CM Smith, MK Proulx, AJ Olive, D Laddy, BB Mishra, C Moss, ... MBio 7 (5), 10.1128/mbio. 01516-16, 2016 | 127 | 2016 |
| Host-pathogen genetic interactions underlie tuberculosis susceptibility in genetically diverse mice CM Smith, RE Baker, MK Proulx, BB Mishra, JE Long, SW Park, HN Lee, ... Elife 11, e74419, 2022 | 86 | 2022 |
| Granulocytes act as a niche for Mycobacterium tuberculosis growth RR Lovewell, CE Baer, BB Mishra, CM Smith, CM Sassetti Mucosal immunology 14 (1), 229-241, 2021 | 67 | 2021 |
| Evaluation of IL-1 blockade as an adjunct to linezolid therapy for tuberculosis in mice and macaques CG Winchell, BB Mishra, JY Phuah, M Saqib, SJ Nelson, P Maiello, ... Frontiers in immunology 11, 891, 2020 | 43 | 2020 |
| Membrane-active antimicrobial peptides and human placental lysosomal extracts are highly active against mycobacteria P Jena, B Mishra, M Leippe, A Hasilik, G Griffiths, A Sonawane Peptides 32 (5), 881-887, 2011 | 31 | 2011 |
| Initial receptor–ligand interactions modulate gene expression and phagosomal properties during both early and late stages of phagocytosis E Hoffmann, S Marion, BB Mishra, M John, R Kratzke, SF Ahmad, ... European journal of cell biology 89 (9), 693-704, 2010 | 28 | 2010 |
| Early innate cell interactions with Mycobacterium tuberculosis in protection and pathology of tuberculosis P Sankar, BB Mishra Frontiers in immunology 14, 1260859, 2023 | 19 | 2023 |
| Evaluation of Berberine as an Adjunct to TB Treatment M Ozturk, JE Chia, R Hazra, M Saqib, RA Maine, R Guler, H Suzuki, ... Frontiers in Immunology 12, 656419, 2021 | 17 | 2021 |
| Synthesis, computational studies, antimycobacterial and antibacterial properties of pyrazinoic acid–isoniazid hybrid conjugates SS Panda, AS Girgis, BB Mishra, M Elagawany, V Devarapalli, ... RSC Advances 9 (20450), 20450–20462, 2019 | 16 | 2019 |
| Mycobacterium tuberculosis acetyltransferase suppresses oxidative stress by inducing peroxisome formation in macrophages A Behera, P Jain, G Ganguli, M Biswas, A Padhi, KP Pattanaik, B Nayak, ... International Journal of Molecular Sciences 23 (5), 2584, 2022 | 11 | 2022 |
| Neutrophils reprograms the bone marrow to impair T-cell immunity during tuberculosis M Saqib, E McDonough, S Das, Z Cheng, P Sankar, F Li, Q Yang, Y Xu, ... bioRxiv, 2022.06. 28.498035, 2022 | 1 | 2022 |
| Repurposed drugs as immune-modulators to combat infectious diseases BB Mishra, M Essafi, R Singh, S Gupta, SP Parihar Frontiers in Immunology 13, 848373, 2022 | 1 | 2022 |
| V-ATPase in cancer progression: Two sides of the same coin M Saqib, BB Mishra Oncotarget 9 (81), 35197, 2018 | 1 | 2018 |
| Pathogenic role for CD101-negative neutrophils in the type I interferon-mediated immunopathogenesis of tuberculosis M Saqib, S Das, TN Nafiz, E McDonough, P Sankar, LK Mishra, X Zhang, ... Cell reports 44 (1), 2025 | | 2025 |
